CARESYNTAX raises €83 million in a Series C funding round for the development of its AI-based surgical tool.
German healthtech company Caresyntax has raised €82.8 million in a Series C funding round. This latest round, led by PFM Health Sciences LP, Optum Ventures, Intel Capital and Lauxera Capital Partners, is one of the largest ever raised by a German healthtech company.
Caresyntax has developed an algorithm-driven tool that analyses risk factors during surgery and recognises critical situations, such as a drop in heart rate. Focused on reducing human error, the tool tracks surgeons and provides them with real-time information, while detecting early warning signs that doctors may not be aware of.
INTERSYSTEMS announces partnership with COGNETIVITY for dementia detection tool
Cognetivity ICA, which can be used on an Apple iPad tablet, can detect early signs of dementia that precede memory symptoms. The solution aims to optimise the treatment and care of dementia patients by enabling earlier intervention to delay the onset of the disease and ultimately reduce mortality.
The AI technology developed by the health visionary is currently the subject of a government-funded study in collaboration with the Sussex Partnership NHS trust and Alzheimer’s Research UK, which has led to the government providing iPads to participants’ homes, enabling them to use the tool remotely.
NEUROELECTRICS secures €14.5 million for a phase 3 clinical trial for the treatment of epilepsy
Spanish start-up Neuroelectrics has secured €14.5 million to fund a phase 3 clinical trial for epilepsy sufferers. The company has just completed a pilot trial involving 20 participants, which showed that Neuroelectrics’ electric neurostimulation helmet, Starstim, reduced seizures in patients with treatment-resistant epilepsy.
Alexander Rotenberg, professor of neurology at Boston Children’s Hospital and Harvard Medical School, and leader of the pilot study, said in a statement that researchers and study participants were looking forward to a non-invasive, non-pharmacological treatment solution for those whose seizures cannot be controlled by drugs or surgery.
Ana Maiques, founder and CEO of Neuroelectrics, added how promising the concept of non-invasive solutions to help patients in need is for the sector, calling it a “beautiful concept”.
MSCA COFUND worth €4.7 million is being awarded to Irish universities to train data analysts.
NeuroInsight, a new London-based research training programme led by the RCSI University of Medicine and Health Sciences, has been awarded a Marie Skłodowska-Curie Actions (MSCA) COFUND worth €4.7 million.
The research training programme will provide 24-month fellowships to 33 researchers who will work on projects at the FutureNeuro and Insight centres. The programme will enable researchers to develop skills in areas such as precision medicine and AI.
NeuroInsight will enable scientists working in Ireland to develop data skills for research into neurological diseases, including motor neurone disease, epilepsy and Parkinson’s disease.
The NeuroInsight Fellowship Programme has been set up by FutureNeuro, the SFI’s research centre for chronic and rare neurological diseases, hosted by the RCSI, in partnership with Insight, the SFI’s research centre for data analytics. The two centres will offer an integrated training programme for researchers, drawing on the respective health and data analytics expertise available at the two SFI centres.
DERBYSHIRE PUBLIC HEALTH partners with ORCHA to launch health tech services
Derbyshire County Council has announced plans to work with the Organisation for the Review of Care and Health Apps (ORCHA) to integrate the use of health apps and technology tools into its services.
The aim is to provide residents with access to quality controlled health and wellbeing apps and will form part of a wider initiative already in place by the county: the Live Life Better Derbyshire healthy living services. This service already offers support for people who want to stop smoking, manage their weight and get active.
Dean Wallace, Derbyshire County Council’s director of public health, said in a statement that the integration of technology will act as a support service to the already comprehensive public health services the council provides to its residents and will be particularly useful where traditional support services are not available. He concluded by explaining that this service will benefit people who are unwilling or unable to use the county’s services and will give them greater control over their health and well-being.